Acute PainNCT07778069
VR for Steroid Joint Injections - Feasibility
A study testing VR-PAT in people with Acute Pain and Procedural Anxiety, run by Nationwide Children's Hospital at 1 site in United States.
Trial summary
The goal of the project is to implement virtual reality for pain and anxiety management for patients undergoing intra-articular glucocorticoid injections in the outpatient pediatric rheumatology clinic. Read more about this study
- Who is it for?
- Ages 5 to 17 years
- Conditions the study is for
- Acute Pain, Procedural Anxiety, Juvenile Idiopahtic Arthritis
- What is being tested?
- VR-PAT
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Oct 2026to Dec 2029
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- rheumatology patients (5-17 years old) who are undergoing an IA glucocorticoid injection in the Nationwide Children's Rheumatology Clinic,
- have a legal guardian present for patients less than 18 years old for the procedure (for informed consent), and
- can communicate orally.
Who cannot join
- any wounds that may interfere with study procedures,
- vision, hearing, or cognitive/motor impairments preventing valid administration of study measures,
- history of motion sickness, seizure disorder, dizziness, or migraine headaches precipitated by visual auras,
- minors in foster care,
- unable to communicate in English,
- pregnant women, or
- prisoners
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Nationwide Children's Hospital
Columbus, Ohio, 43205
About this study
Official title: Virtual Reality Implementation for Pain and Anxiety Management During Intra-articular Glucocorticoid Injections in a Pediatric Rheumatology Clinic
The goal of the project is to implement virtual reality for pain and anxiety management for patients undergoing intra-articular glucocorticoid injections in the outpatient pediatric rheumatology clinic.
Read the detailed description
To assess feasibility of VR use in the clinic, 10 patients will be recruited to use VR during non-sedated intra-articular (IA) glucocorticoid injections. All patients will be offered our typical analgesia (LMX topical cream, freeze spray, lidocaine injection). Patients and caregivers will be asked to fill out pre-injection and post-injection surveys, and staff (rheumatology clinic nurses) will be asked for feedback regarding feasibility of VR in clinical workflows.
The specific aims of the study are to:
Aim 1: Assess the feasibility and efficacy of VR use to reduce pain in patients undergoing non-sedated IA glucocorticoid injections at Nationwide Children's Hospital
- Being tested
- VR-PAT
- Keywords
- Virtual Reality, VR, JIA, Rheumatology
- Medical subject headings
- Acute Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VR-PATOther
Virtual Reality Pain Alleviation Therapeutic (VR-PAT) via a Pico Neo3 Pro Eye
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Participants will be using the VR-PAT during IA glucocorticoid injections Receives: Other: VR-PAT |
What is being measured
The primary outcome is the main question the study is designed to answer.
Practicality/utility of the VR experience as a pain and anxiety management tool for IA joint injection procedures
Assessed by the nurse answering the following questions: "Is this distraction tool helpful during joint injection procedures (Yes/No)?" and "Is this distraction tool easy to use during joint injections (Yes/No)?"
Measured: Immediately following the IA joint injection procedure
Secondary outcomes (2)
Self-reported change procedural anxiety
0-10 Numerical Rating Scale (NRS) (self-reported), 0(min)-10(max), with higher score indicating worse anxiety.
Measured: Immediately before the IA joint injection procedure and immediately after
Self-reported pain
0-10 Numerical Rating Scale (NRS) (self-reported), 0(min)-10(max), with higher score indicating worse pain. Asked for worst pain, average pain, and time spent thinking about pain.
Measured: Immediately following the IA joint injection procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2026
- Study start8 Oct 2026
- Primary completionJul 2029 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nationwide Children's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Henry Xiang, Nationwide Children's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07778069
- Sponsor's protocol ID
- STUDY00005875
- Status last verified
- Oct 2026
- First submitted
- 17 Aug 2026
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No